Previous studies indicated that this transmembrane protein with a single EGF-like and two follistatin domains (TMEFF2) was epigenetically silenced in numerous tumor types, suggesting a potential role as a tumor suppressor35, 36. This evidence concerns the gene FST and neoplasm.